The Association between Gamma-glutamyltransferase and Metabolic Syndrome in Korean Male Workers

한국 직장 남성에서 Gamma-glutamyltransferase와 대사증후군의 관련성

Cho, Young-Gyu;Chung, Hyung-Jin;Cho, Jung-Jin;Paek, Yu-Jin;Park, Kyung-Hee;Byun, Jung-Soo;Song, Hong-Ji
조영규;정형진;조정진;백유진;박경희;변정수;송홍지

  • Published : 20070100

Abstract

The Association between Gamma-glutamyltransferase and Metabolic Syndrome in Korean Male WorkersYoung Gyu Cho, M.D., Hong Ji Song, M.D.*†, Hyung Jin Chung, M.D.*, Jung Jin Cho, M.D.*, Yu Jin Paek, M.D.*, Kyung Hee Park, M.D.*, Jung Soo Byun, M.D.*

연구배경: 혈청 Gamma-glutamyltransferase (GGT)는 임상에서 과도한 음주와 간 질환의 표지자로 사용되고 있지만, 최근 심혈관 질환과 연관되어 있다는 보고가 있다. 본 연구에서는 GGT와 여러 심혈관계 위험인자들의 군집 질환인 대사증후군과의 관련성을 알아보고자 한다. 방법: 2003년 5월부터 10월까지 일개 대학병원 건강증진센터에서 직장 검진을 실시한 직장 남성 1,215명을 대상으로 설문조사, 혈액검사 및 복부 초음파를 시행하여 총 콜레스테롤, 중성지방, 고밀도 지단백 콜레스테롤, 체질량지수 (body mass index, BMI), 허리둘레, 혈압, 공복 혈당, 요산, GGT, 지방간 여부를 측정하여 GGT와 대사증후군과의 관계를 분석하였다. 결과: 연구대상자의 평균 연령은 41.9±7.2세, 평균 체질량지수는 24.1±2.7 kg/m2였다. GGT가 상승한 군(GGT>75 IU/L)은 172명(15.1%)이었고, 대사증후군의 유병률은 9.9% (112/1136)였다. 대사증후군으로 진단된 군의 평균 GGT는 53.4 IU/L로 대사증후군이 없는 군의 평균 34.4 IU/L보다 의미 있게 높았다. 다변량 분석에서도 GGT 상승군은 정상군에 비해 대사증후군의 위험이 유의하게 높았으며(OR=2.835), 이러한 위험의 증가는 복부 초음파상 지방간 등의 간 이상 소견이 없는 군, alanine aminotransferase (ALT)가 정상인 군(ALT≤43 IU/L), 음주량이 경도 이하인 군(음주량≤24 g/day), 정상 체중인 군(BMI<23 kg/m2)을 선별하여 다변량 분석을 하였을 때에도 변함이 없었다. 결론: 한국 성인 직장 남성에서 GGT는 대사증후군과 밀접한 관련이 있었으며, GGT 증가가 대사증후군의 또 다른 특징이 될 수 있음을 보여주었다.

Keywords

References

  1. Rollason JG, Pincherle G, Robinson D. Serum gamma glutamyl transpeptidase in relation to alcohol consumption. Clin Chim Acta 1972;39(1):75-80 https://doi.org/10.1016/0009-8981(72)90301-4
  2. Poikolainen K, Karkkainen P, Pikkarainen J. Correlations between biological markers and alcohol intake as measured by diary and questionnaire in men. J Stud Alcohol 1985;46(5): 383-7 https://doi.org/10.15288/jsa.1985.46.383
  3. Nilssen O, Forde OH, Brenn T. The Tromso Study. Distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 1990:132(2):318-26 https://doi.org/10.1093/oxfordjournals.aje.a115661
  4. Nakanishi N, Nakamura K, Suzuki K, Tatara K. Lifestyle and serum gamma-glutamyltransferase: a study of middle-aged Japanese men. Occup Med (Lond) 2000;50(2):115-20 https://doi.org/10.1093/occmed/50.2.115
  5. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000;31(8):1851-5 https://doi.org/10.1161/01.STR.31.8.1851
  6. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142(7):699-708 https://doi.org/10.1093/oxfordjournals.aje.a117699
  7. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Clin Chem 2003;49(8):1358-66 https://doi.org/10.1373/49.8.1358
  8. 임지선, 김유진, 천병렬, 양진훈, 이덕희, 감 신. 정상 범위내 혈청 GGT와 심혈관계 질환의 위험요인과의 관련성. 예방의학회지 2005;38(1):101-6
  9. Lee DH, Ha MH, Kam S, Chun B, Lee J, Song K, et al. A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among south Korean men. Am J Epidemiol 2006;163(1):57-65 https://doi.org/10.1093/aje/kwj006
  10. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. Gamma-glutamyltransferase and diabetes - a 4 year follow-up study. Diabetologia 2003;46(3):359-64 https://doi.org/10.1007/s00125-003-1036-5
  11. U.S. Preventive Service Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med 2004; 140(7):554-6 https://doi.org/10.1001/archinte.140.4.554
  12. WHO West Pacific Region. The Asia-Pacific perspective: Redefining obesity and its treatment. IOTF. 2000. Available from:URL:http://www.diabetes.com.au/pdf/obesity_report.pdf
  13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285(19):2486-97 https://doi.org/10.1001/jama.285.19.2486
  14. Farrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34(6):416-22 https://doi.org/10.1007/BF00403180
  15. Gray RS, Fabisitz RR, Cowan LD, Lee ET, Howard BV, Savage PJ. Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study. Am J Epidemiol 1998; 148(9):869-78 https://doi.org/10.1093/oxfordjournals.aje.a009712
  16. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9 https://doi.org/10.2337/diacare.24.4.683
  17. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16 https://doi.org/10.1001/jama.288.21.2709
  18. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3):356-9 https://doi.org/10.1001/jama.287.3.356
  19. 임열리, 황승욱, 심현준, 오은혜, 장유수, 조비룡. ATP III의 진단기준에 따른 대사증후군의 유병률과 관련위험요인 분석. 가정의학회지 2003;24:135-43
  20. 박정식, 박현덕, 윤중원, 정찬희, 이원영, 김선우. 도시지역 검진수진자 40,698명에서 NCEP-ATPIII 기준에 의한 대사증후군의 유병률. 대한내과학회지2002;63:290-8
  21. Vernay M, Balkau B, Moreau JG, Sigalas J, Chesnier MC, Ducimetiere P, et al. Alcohol consumption and insulin resistance syndrome parameters: associations and evolutions in a longitudinal analysis of the French DESIR cohort. Ann Epidemiol 2004;14:209-14 https://doi.org/10.1016/S1047-2797(03)00131-5
  22. van Tol A, Hendriks HF. Moderate alcohol consumption:effects on lipids and cardiovascular disease risk. Curr Opin Lipidol 2001;12(1):19-23 https://doi.org/10.1097/00041433-200102000-00004
  23. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, et al. Nonalcohoilic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002;35(2):367-72 https://doi.org/10.1053/jhep.2002.30690
  24. van Barneveld T, Seidell JC, Traag N, Hautvast JG. Fat distribution and gamma-glutamyl transferase in relation to serum lipids and blood pressure in 38-year old Dutch males. Eur J Clin Nutr 1989;43:809-18
  25. Sakugawa H, Nakayoshi T, Kobashigawa K, Nakasone H, Kawakami Y, Yamashiro T, et al. Metabolic syndrome is directly associated with gamma glutamyl transpeptidase elevation in japanese women. World J Gastroenterol 2004;10:1052-5 https://doi.org/10.3748/wjg.v10.i7.1052
  26. Shi M, Gozal E, Choy HA, Forman HJ. Extracellular glutathione and gamma-glutamyl transpeptidase prevent H2O2-induced injury by 2,3-dimethoxy-1,4-naphthoquinone. Free Radic Biol Med 1993;15(1):57-67 https://doi.org/10.1016/0891-5849(93)90125-E
  27. Tian L, Shi MM, Forman HJ. Increased transcription of the regulatory subunit of gamma-glutamylcysteine synthetase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion. Arch Biochem Biophys 1997;342(1):126-33 https://doi.org/10.1006/abbi.1997.9997
  28. Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J Investig Med 1999;47(3):151-60
  29. Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M. Gamma-glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998;25(7):786-92 https://doi.org/10.1016/S0891-5849(98)00127-0
  30. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004;38(6):535-9 https://doi.org/10.1080/10715760410001694026